Document:

exv10w20

 

EXHIBIT
10.20

[Form of Executive Change of Control Agreement – Full Double-Trigger]

[Date]

[Name]

[Title]

Callidus Software Inc.

160 West Santa Clara Street

San Jose, CA 95113

Dear [Name]:

This letter modifies any Stock Option Agreement (“Option Agreement”) or Employment Agreement you
may now or hereafter have with respect to the common stock of Callidus Software, Inc. (the
“Company”) and any prior agreement between you and the Company regarding the Option Agreements
including, without limitation, any prior change of control agreement(s). This letter provides for
accelerated vesting of the options subject to the Option Agreements (the “Options”) under the
conditions described below.

Notwithstanding the provisions set forth in the prior paragraph, if you previously entered into any
agreement with the Company that provides for full vesting of all of your options on a change of
control of the Company, this letter shall not modify such prior agreement as it relates to any
option granted to you prior to March 14, 2006. However, for all options granted to you after March
14, 2006, the terms of this letter shall control.

If, within 18 months after a “Change in Control,” your employment is terminated by the Company
without “Cause” or by you for “Good Reason,” you shall receive 100% vesting of your Options.

     For purposes of the above:

	 	(a)	 	“Cause” means the occurrence of any one or more of the following:

	 	(i)	 	any material act of misconduct or dishonesty by you in the performance of your
duties;
	 
	 	(ii)	 	any willful and material failure by you to perform your duties;

 

 

	 	(iii)	 	any material breach of any employment agreement, confidentiality agreement or
proprietary information agreement;
	 
	 	(iv)	 	your conviction of (or pleading guilty or nolo contendere to) a misdemeanor
involving theft, embezzlement, dishonesty or moral turpitude or a felony;

provided that in the case of clauses (i) through (iii), you shall have a period of 30 days
from written notice by the Company to cure such action or omission unless not reasonably
susceptible of cure.

	 	(b)	 	“Good Reason” means

	 	(i)	 	any reduction in your base salary or annual target bonus;
	 
	 	(ii)	 	any material reduction in your other benefits;
	 
	 	(iii)	 	any material reduction in your duties, responsibilities, or authority; or
	 
	 	(iv)	 	a requirement that you relocate to a location more than 35 miles from your
then current office location.

	 	(c)	 	“Change in Control” means:

	 	(i)	 	The acquisition by any “person” (as such term is used in Sections 13(d) and 14(d)
of the Exchange Act) of “beneficial ownership” (as defined in Rule 13d-3 under said Act),
directly or indirectly, of securities of the Company representing fifty percent (50%) or
more of the total voting power represented by the Company’s then outstanding voting
securities (it being understood that securities owned by any person on the date hereof
shall not be counted against such limit with respect to such person); or
	 
	 	(ii)	 	A change in the composition of the Board of Directors of the Company (the
“Board”) occurring within a rolling two- year period, as a result of which fewer than a
majority of the directors are Incumbent Directors. “Incumbent Directors” shall mean
directors who either (A) are members of the Board as of the date hereof, or (B) are
elected, or nominated for election, to the Board with the affirmative votes of at least a
majority of the Incumbent Directors at the time of such election or nomination (but shall
not include an individual not otherwise an Incumbent Director

2

 

	 	 	 	whose election or nomination is in connection with an actual or threatened proxy
contest relating to the election of directors to the Board); or
	 
	 	(iii)	 	A merger or consolidation involving the Company other than a merger or
consolidation which would result in the voting securities of the Company outstanding
immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the Surviving Entity (including the parent
corporation of such Surviving Entity)) at least fifty percent (50%) of the total voting
power represented by the voting securities of the Company or such Surviving Entity
outstanding immediately after such merger or consolidation, or a sale or disposition by
the Company of all or substantially all the Company’s assets.

The term “Surviving Entity” shall refer to the entity surviving the merger, consolidation or sale
of substantially all of the assets and continuing with the assets or business of the Company in the
case of a Change of Control event described in clause (iii) above.

     The modification to the terms of the vesting schedule of your Options as described in this letter
has been approved by the Board and is effective immediately.

Sincerely,

[Callidus Software, Inc. Officer]

[Title]

AGREED AND ACCEPTED this ____ day of [Month and Year].

	 	 	 
	 	 	 
	[Name]

	 	 

3exv10w21

 

Exhibit 10.21

	 	 	 	 	 
	ROBERT C. SCHUBERT (STATE BAR NO. 62684)
	JUDEN JUSTICE REED (STATE BAR NO. 153748)
	WILLEM F. JONCKHEER (STATE BAR NO. 178748)
	AARON H. DARSKY (STATE BAR NO. 212229)
	SCHUBERT & REED LLP
	Three Embarcadero Center, Suite 1650
	San Francisco, CA 94111
	Telephone: (415) 788-4220
	 
	 	 	 	 
	BRIAN J. ROBBINS (STATE BAR NO. 190264)
	MARC M. UMEDA (STATE BAR NO. 197847)
	ROBBINS UMEDA & FINK, LLP
	610 West Ash Street, Suite 1800
	San Diego, CA 92101
	Telephone:

	 	(619) 525-3990	 	 
	Facsimile:

	 	(619) 525-3991	 	 
	 
	 	 	 	 
	Attorneys for Plaintiff Henry Ramseur, Derivatively
	on behalf of Callidus Software Inc.
	 
	 	 	 	 
	 
	 	 	 	 
	WILLIAM F. ALDERMAN (STATE BAR NO. 47381)
	JAMES N. KRAMER (STATE BAR NO. 154709)
	M. TODD SCOTT (STATE BAR NO. 226885)
	ORRICK, HERRINGTON & SUTCLIFFE LLP
	The Orrick Building
	405 Howard Street
	San Francisco, CA 94105-2669
	Telephone:

	 	415-773-5700	 	 
	Facsimile:

	 	415-773-5759	 	 
	 
	 	 	 	 
	Attorneys for Defendants
	 
	 	 	 	 
	 
	 	 	 	 
	UNITED STATES DISTRICT COURT

	 
	 	 	 	 
	NORTHERN DISTRICT OF CALIFORNIA

	 
	 	 	 	 
	SAN FRANCISCO DIVISION

	 
	 	 	 	 

	 	 	 	 	 	 
	HENRY RAMSEUR, Derivatively on behalf	 	 	Case No.   C 04-4419 SI (JCS)
	of CALLIDUS SOFTWARE INC., a	 	 	 
	DELAWARE CORPORATION,	 	 	STIPULATION OF SETTLEMENT
	 
	 	 	 	 	 
	                    Plaintiff,	 	 	 
	 
	 	 	 	 	 
	          v.	 	 	 
	 
	 	 	 	 	 
	GEORGE JAMES, R. DAVID SPRENG,	 	 	 
	TERRY L. OPDENDYK, MICHAEL A.	 	 	 
	BRAUN, JOHN R. EICKHOFF,	 	 	 
	CHRISTOPHER W. CABRERA and REED	 	 	 
	D. TAUSSIG,	 	 	 
	 
	 	 	 	 	 
	                    Defendants.	 	 	 
	 
	 	 	 	 	 
	          — and —	 	 	 
	 
	 	 	 	 	 
	CALLIDUS SOFTWARE INC., a	 	 	 
	DELAWARE CORPORATION,	 	 	 
	 
	 	 	 	 	 
	 
	 	 	 	 	 
	                    Nominal Defendant.	 	 	 
	 
	 	 	 	 	 
	 	 	 	 

Stipulation Of Settlement

C 04-4419 SI (JCS)

 

 

          This stipulation of settlement (the “Stipulation”) is entered into as of August 11, 2006 by
(a) the following parties to this action (the “Action”): plaintiff Henry Ramseur, derivatively on
behalf of Callidus Software Inc., a Delaware corporation (“Callidus”); Callidus; and defendants
George James, R. David Spreng, Terry L. Opdendyk, Michael A. Braun, John R. Eickhoff, Christopher
W. Cabrera and Reed D. Taussig (collectively “Defendants”); and (b) the following additional
parties to an action entitled “Brett Cashman, derivatively on behalf of Callidus Software, Inc. v.
George James, et al.,” No. 104 CV 024198 in the Superior Court of California for Santa Clara County
(the “Cashman Action”): plaintiff Brett Cashman, derivatively on behalf of Callidus; and
defendants David Pratt, Ronald J. Fior and Onset Ventures (the “Cashman Defendants”).

          WHEREAS, the Action was filed on October 19, 2004, derivatively on behalf of Callidus; and

          WHEREAS, the Cashman Action was filed on July 30, 2004, derivatively on behalf of Callidus,
and named as defendants the Defendants (other than Christopher Cabrera) and the Cashman Defendants;
and

          WHEREAS, the Defendants and the Cashman Defendants are insureds under a policy of Directors
and Officers Liability Insurance issued by Genesis Insurance Company (“Genesis”), policy no.
YXB002544 (the “Policy”); and

          WHEREAS, plaintiff in the Action is represented by the law firms of Schubert & Reed LLP and
Robbins Umeda & Fink, LLP; plaintiff in the Cashman Action is represented by

Stipulation Of Settlement

C 04-4419 SI (JCS)

-2-

 

the law firm of Robbins Umeda & Fink, LLP (collectively, “Plaintiffs’ Counsel”); and
Plaintiffs’ Counsel have cooperated in the prosecution of both actions and in the negotiation of
the settlement terms set forth in this Stipulation; and

          WHEREAS, the parties in the Action and the Cashman Action participated in a court-ordered
settlement conference before Hon. Joseph Spero on August 1, 2006 and subsequently engaged in
additional settlement negotiations; and

          WHEREAS, the Defendants and the Cashman Defendants deny any and all liability in the Action
and the Cashman Action; and

          WHEREAS, plaintiffs in the Action and the Cashman Action (collectively, “Plaintiffs”),
Plaintiffs’ Counsel, the Defendants, the Cashman Defendants and Genesis all believe it to be in the
best interest of Callidus and of all parties in both actions to compromise and settle the Action
and the Cashman Action on the terms set forth below (the “Settlement”);

          NOW, THEREFORE, the Plaintiffs, the Defendants, the Cashman Defendants and Genesis, by and
through their respective undersigned attorneys or representatives, hereby stipulate and agree as
follows:

          1. Within five business days after the Settlement becomes effective, as defined below (the
“Effective Date”), Callidus shall adopt, formalize and/or reconfirm the corporate governance
policies set forth in Exhibit A hereto and shall keep them in effect for at least three years
thereafter. The parties acknowledge that those policies confer a substantial benefit on Callidus
and resulted substantially from the prosecution of the Action and the Cashman Action.

          2. Within five business days after entry of the Final Judgment (defined below), and in
recognition of the benefits conferred on Callidus, Genesis shall pay to Plaintiffs’ Counsel the sum
of $397,000 as attorney’s fees and expenses, together with an incentive award payable to each
named plaintiff of $1,500, subject to Court approval (resulting in total payments by Genesis of
$400,000); provided, however, that in the event the Final Judgment is reversed or vacated on
appeal, Plaintiffs’ Counsel and Plaintiffs shall, within five business days after such vacatur or
reversal, repay such $397,000 and $3,000, respectively, to Genesis together with

Stipulation Of Settlement

C 04-4419 SI (JCS)

-3-

 

interest thereon calculated, from the date of Genesis’ payment to the date of Plaintiffs’
Counsel’s repayment, in the manner provided by 28 U.S.C. § 1961.

          3. Upon the Effective Date, Plaintiffs, Callidus, and each of Callidus’ present and former
shareholders to the extent they seek to sue derivatively on behalf of Callidus, shall be deemed to
release and forever discharge each of the Defendants, each of the Cashman Defendants, and each of
the present and former directors and officers of Callidus, together with their respective present
and former partners, agents, predecessors, successors, heirs, executors, representatives, assigns,
beneficiaries, insurers (including but not limited to Genesis) and attorneys, from and against any
and all claims, demands, actions, causes of action, liabilities, damages, costs, expenses, debts
and attorney’s fees, whether past or present, known or unknown, suspected or unsuspected, which any
of them has, has had, or may in the future claim to have had, arising out of or in connection with
or in any way relating to any act, occurrence, omission, transaction, fact, matter, stock sale or
circumstance that is or could have been alleged in the Action or the Cashman Action, including
without limitation any matter insured under the Policy (“Claims”).

          4. Plaintiffs and Plaintiffs’ Counsel acknowledge that they or other Callidus shareholders may
hereafter discover facts or damages in addition to or different from those they now know or believe
to exist with respect to the subject matter of the release contained in paragraph 3 above and have
negotiated and entered into this Stipulation with full knowledge of such a possibility.
Nevertheless, Plaintiffs and Plaintiffs’ Counsel waive any and all rights they or other Callidus
shareholders may have under any law or statute that would limit the effect of such release to
claims that are known or suspected; provided, however, that such waiver does not extend to any
Claims relating to the possible backdating of Callidus stock option grants, none of which is
presently known to the parties or their counsel, that may hereafter be discovered. Such waiver
specifically includes the protections and benefits of Section 1542 of the California Civil Code,
which provides:

“A general release does not extend to claims which the creditor does
not know or suspect to exist in his favor at the time of executing
the release, which if known by him must have materially

Stipulation Of Settlement

C 04-4419 SI (JCS)

-4-

 

affected his settlement with the debtor.”

          5. Upon the Effective Date, Callidus, Defendants, and each of Callidus’ present shareholders
to the extent they seek to sue derivatively on behalf of Callidus, shall be deemed to release and
forever discharge each of the Plaintiffs and Plaintiffs’ counsel from any claim arising from the
prosecution and settlement of the Action and the Cashman Action.

          6. As soon as practicable after all parties have executed this Stipulation, Plaintiffs’
Counsel shall present it to the Court in the Action for preliminary approval, together with an
appropriate motion for preliminary approval and a proposed Preliminary Approval Order in the form
attached as Exhibit B to this Stipulation.

          7. Within fifteen business days after entry of the Preliminary Approval Order, substantially
in the form of Exhibit B hereto, Callidus, at its expense, shall (a) cause copies of a Settlement
Notice, substantially in the form of Exhibit C hereto, to be sent by first-class mail, postage
pre-paid, to all present Callidus shareholders at their last known addresses as appearing in the
records maintained by Callidus’ transfer agent, and (b) post the Settlement Notice in the investor
relations section of its website. Subsequent to mailing the Settlement Notice, and no less than
five days before the Final Approval Hearing, Callidus shall file with the Court and serve on
Plaintiffs’ Counsel a declaration attesting that the Settlement Notice was duly mailed and posted
in accordance with the Preliminary Approval Order.

          8. The Final Approval Hearing shall be held within 45 days, or such other period as the Court
directs, after mailing of the Settlement Notice to Callidus’ shareholders. No later than ten days
before the Final Approval Hearing, Plaintiffs’ Counsel shall file a motion for final approval of
the Settlement with the Court. At or before the Final Approval Hearing, the parties to the Action
shall jointly submit to the Court a proposed Final Judgment in the form attached as Exhibit D to
this Stipulation.

          9. Entry of a Final Judgment in substantially the form of Exhibit D hereto shall be a
condition precedent to the effectiveness of the Settlement. The Effective Date of the Settlement
shall be: (a) if no notice of appeal from the Final Judgment is filed, the 31st day after entry of
the Final Judgment (or, if such day is not a business day then the next succeeding

Stipulation Of Settlement

C 04-4419 SI (JCS)

-5-

 

business day); or (b) if a notice of appeal from such Final Judgment is filed, the day after
the Final Judgment is affirmed or the appeal is dismissed, and the Final Judgment is no longer
subject to further judicial review.

          10. Within five days after the Effective Date, plaintiff’s counsel in the Cashman Action shall
file a dismissal with prejudice in the Cashman Action. Between the time this Stipulation is
executed and the time said dismissal is filed, counsel for the parties in the Cashman Action shall
cooperate in obtaining a stay of that action or a standstill agreement preventing further activity
in the Cashman Action.

          11. If for any reason the Effective Date does not occur, then the Settlement shall become null
and void, the parties in the Action and the Cashman Action shall be returned to the positions they
had prior to the execution of the Stipulation, and any funds paid to Plaintiffs’ Counsel by
Genesis pursuant to paragraph 2 above shall be repaid to Genesis with interest, as provided
therein.

          12. This Stipulation may be executed in two or more counterparts, all of which together shall
constitute the entire Stipulation.

          13. This Stipulation, and the Exhibits hereto, constitute the sole and entire agreement of the
parties to this Stipulation with respect to the Settlement, and no representations, warranties,
promises, inducements or agreements, oral or written, not embodied herein have been made in
connection with the Settlement. The provisions of this Stipulation may be modified by written
agreement of the parties hereto, by and through their respective counsel.

          14. This Stipulation shall be governed and construed in accordance with the laws of the State
of California and, to the extent applicable, by Rule 23.1 of the Federal Rules of Civil Procedure.

          15. Neither this Stipulation nor the Settlement, or any of the negotiations or proceedings in
connection therewith, shall be construed as or deemed to be evidence, or any admission or
concession, by any of the Defendants or Cashman Defendants of any wrongdoing or liability
whatsoever, which is hereby expressly denied and disclaimed by each of them. Neither this
Stipulation and the fact of its execution nor any of its provisions shall be offered or received

Stipulation Of Settlement

C 04-4419 SI (JCS)

-6-

 

in evidence in any action or proceeding or otherwise referred to or used in any manner in any
court or tribunal, except to enforce the terms of the Settlement.

          16. This Stipulation has been prepared jointly by the parties hereto and their counsel and
shall not be construed more strictly against any of them by reason of their contributions to the
negotiation and preparation of the Stipulation.

	 	 	 	 	 
	Dated: August 10, 2006	 	SCHUBERT & REED LLP
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	/s/ Robert C. Schubert
	 	 	 
	 	 	Robert C. Schubert

	 	 	Attorneys for Plaintiff Henry Ramseur

	 
	 	 	 	 
	 
	 	 	 	 
	Dated: August 10, 2006	 	ROBBINS UMEDA & FINK LLP
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	/s/ Marc Umeda
	 	 	 
	 	 	Marc Umeda

	 	 	Attorneys for Plaintiff Henry Ramseur, and for

	 	 	Plaintiff Brett Cashman in the Cashman Action

	 
	 	 	 	 
	 
	 	 	 	 
	Dated: August 11, 2006	 	ORRICK, HERRINGTON & SUTCLIFFE LLP
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	/s/ William F. Alderman
	 	 	 
	 	 	William F. Alderman

	 	 	Attorneys for Defendants and

	 	 	Cashman Defendants

	 
	 	 	 	 
	 
	 	 	 	 
	Dated: August 11, 2006	 	GENESIS INSURANCE COMPANY
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	/s/ Michelle Lafferty
	 	 	 
	 	 	Michelle Lafferty

	 
	 	 	 	 
	 

	 	Title:
	 	Attorney
	 

	 	 	 	 

Stipulation Of Settlement

C 04-4419 SI (JCS)

-7-

 

	 	 	 	 	 
	Dated: August 11, 2006	 	CALLIDUS SOFTWARE INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Paul F. Katawicz
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:
	 	Sr. Corp. Counsel and Assistant Secretary
	 

	 	 	 	 

Stipulation Of Settlement

C 04-4419 SI (JCS)

-8-

 

Corporate Governance Matters

Board of Directors

	 	•	 	The Board shall adopt a “Pfizer” style policy providing that director nominees receiving a
greater number of withheld votes than votes for in an uncontested election must tender their
resignation. The Nominating and Governance Committee, or the full board, shall then decide
within a specified time period whether to accept the resignation.
	 
	 	•	 	The Corporate Governance Guidelines shall be amended to include a provision that management
will keep the board informed of all relevant information for purposes of the Board carrying
out its duties.
	 
	 	•	 	The Board shall continue to elect its Chairman from the independent directors.

Executive Compensation

	 	•	 	The Company shall put all performance reviews for executive officers in writing. To the
extent that the Compensation Committee determines that performance based compensation outside
of established written plans for executive officers is appropriate, the Committee shall submit
recommendations for such compensation to the full Board for approval. Such recommendations
shall contain a statement of the reasons the Committee believes a departure from the Company’s
established performance objectives is desirable.
	 
	 	•	 	The Company shall formalize its policies that prevent the back-dating of stock options and
require regular review of stock option exercises to prevent irregularities in timing of
exercises.

Insider Trading

	 	•	 	The Company shall add consideration of the imposition of a “Trading Freeze” under the
Company’s Corporate Policy and Procedure on Insider Trading as a formal agenda item for all
regularly scheduled meetings of the Board.

Code of Conduct

	 	•	 	The job description of the general counsel shall be amended to provide that, in addition to
existing duties, the general counsel shall (i) oversee and administer the Company’s Code of
Conduct and Ethics; (ii) foster a culture that integrates compliance and ethics into business
processes and practices through awareness and training; and (iii) maintain and monitor a
system for reporting and investigating potential violations of the Code of Conduct and other
potential compliance and ethics concerns. In addition, the general counsel shall report
directly to the Audit Committee as appropriate regarding the Company’s Code of Business
Conduct and corporate compliance matters.

EXHIBIT A

 

 

Audit Committee

	 	•	 	The Audit Committee charter shall be revised to provide that the Audit Committee (or the
full Board) shall review all revenue and earnings guidance proposed to be provided by the
Company to analysts, ratings agencies, and/or the public market, including any such guidance
to be provided in earnings or press releases. Such review shall include the participation of
the Company’s Chief Executive Officer, Chief Financial Officer, and any other executive or
employee of the Company as the Audit Committee (or the full Board) deems appropriate. No
revenue or earnings guidance shall be released in any form without prior review by the Audit
Committee (or the Full Board).
	 
	 	•	 	The Audit Committee (or the full Board) shall receive from management such information as
it deems necessary to support any proposed revenue or earnings guidance to be provided by the
Company.
	 
	 	•	 	At each meeting at which the Audit Committee is requested to approved revenue or earnings
guidance, it shall receive from management a detailed report regarding the Company’s history
in meeting prior guidance. Such report shall describe the reasons for any discrepancies
between guidance provided and results achieved by the Company.

2

 

ROBERT C. SCHUBERT (STATE BAR NO. 62684)

JUDEN JUSTICE REED (STATE BAR NO. 153748)

WILLEM F. JONCKHEER (STATE BAR NO. 178748)

AARON H. DARSKY (STATE BAR NO. 212229)

SCHUBERT & REED LLP

Three Embarcadero Center, Suite 1650

San Francisco, CA 94111

Telephone: (415) 788-4220

BRIAN J. ROBBINS (STATE BAR NO. 190264)

MARC M. UMEDA (STATE BAR NO. 197847)

ROBBINS UMEDA & FINK, LLP

610 West Ash Street, Suite 1800

San Diego, CA 92101

Telephone: (619) 525-3990

Facsimile: (619) 525-3991

Attorneys for Plaintiff Henry Ramseur, Derivatively

on behalf of Callidus Software Inc.

WILLIAM F. ALDERMAN (STATE BAR NO. 47381)

JAMES N. KRAMER (STATE BAR NO. 154709)

M. TODD SCOTT (STATE BAR NO. 226885)

ORRICK, HERRINGTON & SUTCLIFFE LLP

The Orrick Building

405 Howard Street

San Francisco, CA 94105-2669

Telephone: 415-773-5700

Facsimile: 415-773-5759

Attorneys for Defendants

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

	 	 	 	 	 	 
	HENRY RAMSEUR, Derivatively on behalf	 	 	Case No.   C 04-4419 SI (JCS)
	of CALLIDUS SOFTWARE INC., a	 	 	 
	DELAWARE CORPORATION,	 	 	ORDER GRANTING PRELIMINARY

APPROVAL OF DERIVATIVE

	                    Plaintiff,	 	 	ACTION SETTLEMENT AND

DIRECTING MAILING OF NOTICE
	 
	 	 	 	 	 
	          v.	 	 	 
	 
	 	 	 	 	 
	GEORGE JAMES, R. DAVID SPRENG,	 	 	 
	TERRY L. OPDENDYK, MICHAEL A.	 	 	 
	BRAUN, JOHN R. EICKHOFF,	 	 	 
	CHRISTOPHER W. CABRERA and REED	 	 	 
	D. TAUSSIG,	 	 	 
	 
	 	 	 	 	 
	                    Defendants.	 	 	 
	 
	 	 	 	 	 
	          — and —	 	 	 
	 
	 	 	 	 	 
	CALLIDUS SOFTWARE INC., a	 	 	 
	DELAWARE CORPORATION,	 	 	 
	 
	 	 	 	 	 
	 
	 	 	 	 	 
	                    Nominal Defendant.	 	 	 
	 
	 	 	 	 	 
	 	 	 	 

ORDER GRANTING PRELIMINARY APPROVAL OF

DERIVATIVE ACTION SETTLEMENT AND DIRECTING

MAILING OF NOTICE

C 04-4419 SI (JCS)

 

 

          This matter came before the Court on August 11, 2006 for preliminary approval of the proposed
settlement (the “Settlement”) in this derivative action described in the Stipulation of Settlement,
dated as of August 11, 2006 and filed with the Court on August 11, 2006.

          The Court having read the Stipulation and having concluded that the Settlement described in
the Stipulation appears, subject to the Final Approval Hearing described below and any further
papers filed in connection therewith, to be fair, reasonable and adequate and in the best interests
of Callidus Software Inc. (“Callidus”), and good cause appearing therefor, it is hereby ORDERED as
follows:

          1. Pursuant to Rule 23.1 of the Federal Rules of Civil Procedure (“Rule 23.1”), the Court
preliminarily approves the Settlement described in the Stipulation, subject to further
consideration at the Final Approval Hearing described below.

          2. A hearing (the “Final Approval Hearing”) shall be held before this Court on October 27,
2006 at 9:00 a.m. to determine whether the proposed Settlement on the terms and conditions
described in the Stipulation is fair, reasonable and adequate and is in the best interests of
Callidus and should be finally approved, and whether the Final Judgment described in the
Stipulation should be entered. The Court may adjourn the Final Approval Hearing without further
notice to Callidus shareholders.

          3. The Court approves as to form and content the Settlement Notice attached as Exhibit C to
the Stipulation and directs Callidus, at its expense, to mail the Settlement Notice to Callidus
shareholders of record on or before August 21, 2006. The Court finds that said mailing, and its
posting on the investor relations section of the Callidus website, as provided in

ORDER GRANTING PRELIMINARY APPROVAL OF

DERIVATIVE ACTION SETTLEMENT AND DIRECTING

MAILING OF NOTICE

C 04-4419 SI (JCS)

- 2 -

 

the Stipulation, constitutes due and adequate notice under Rule 23.1 and satisfies the
requirements of due process. Not less than five days before the Final Approval Hearing, Callidus
shall file with the Court and serve on Plaintiffs’ Counsel a declaration attesting that the
Settlement Notice was duly mailed and posted in accordance with this Order.

          4. Pending final determination of whether the Settlement should be approved, this action is
stayed in all respects other than steps directed to consummation of the Settlement, and plaintiff
shall not commence or prosecute any action or proceeding on behalf of Callidus or against any of
the parties to be released by the Stipulation.

          5. Any Callidus shareholder may appear at the Final Approval Hearing and show cause, if any,
why the proposed Settlement should or should not be finally approved; provided, however, that no
shareholder will be heard unless, at least 10 days before the Final Approval Hearing, he or she has
filed with the Court a written statement of his or her position, together with any supporting
papers, showing proof of service of the papers on Juden Justice Reed and William F. Alderman at the
addresses provided in the Settlement Notice. Unless otherwise directed by the Court, any Callidus
shareholder who has not made an objection to the Settlement in the manner described above will be
deemed to have waived it.

          6. All papers in support of the Settlement shall be filed with the Court and served on all
counsel no less than seven days prior to the Final Approval Hearing.

	 	 	 	 	 
	 	 	 
	Dated: August 11, 2006 	/s/ Susan Illston
 	 
	 	United States District Judge 	 
	 	 	 
	 

ORDER GRANTING PRELIMINARY APPROVAL OF

DERIVATIVE ACTION SETTLEMENT AND DIRECTING

MAILING OF NOTICE

C 04-4419 SI (JCS)

- 3 -

 

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

	 	 	 	 	 	 	 	 
	HENRY RAMSEUR, Derivatively on behalf of CALLIDUS	 	 	 
	SOFTWARE INC., a DELAWARE CORPORATION,	 	 	Case No. C 04-4419 SI (JCS)
	 
	 	 	 	 	 	 	 
	 

	 	 	Plaintiff,	 	 	NOTICE OF SETTLEMENT
	 
	 	 	 	 	 	 	 
	 

	 	v.	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	GEORGE JAMES, ET AL.,	 	 	 
	 
	 	 	 	 	 	 	 
	 

	 	 	Defendants.	 	 	 
	 
	 	 	 	 	 	 	 
	 

	 	— and —	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	CALLIDUS SOFTWARE INC., a DELAWARE CORPORATION,	 	 	 
	 
	 	 	 	 	 	 	 
	 

	 	 	Nominal Defendant.	 	 	 
	 	 	 	 

			
	TO:	 	ALL SHAREHOLDERS OF CALLIDUS SOFTWARE INC.:

     PLEASE TAKE NOTICE that on October 27, 2006 at 9:00 a.m., in the courtroom of United States
District Judge Hon. Susan Illston, Courtroom No. 10, 19th Floor, 450 Golden Gate Avenue, San
Francisco, California, a proposed settlement of the above-entitled shareholder derivative action
will be presented to the Court for final approval pursuant to Rule 23.1 of the Federal Rules of
Civil Procedure.

     At the October 27 hearing, the Court will consider whether the proposed settlement is in the
best interest of Callidus Software Inc. (“Callidus”), for whose benefit this derivative action has
been brought, and should be approved as fair, reasonable and adequate; whether a final judgment
should be entered dismissing the action with prejudice and releasing all claims against the
defendants that were or could have been asserted in the action; and whether the attorney’s fees and
expenses, and the incentive awards to plaintiffs, provided by the proposed settlement should be
approved.

     This notice is being sent to you as a Callidus shareholder to advise you of the pendency of
the action, inform you of the proposed settlement and provide you with an opportunity to be heard
at the final approval hearing, if you so desire.

THIS NOTICE IS PURELY INFORMATIONAL. YOU ARE RECEIVING IT BECAUSE THE LAW REQUIRES THAT
CALLIDUS SHAREHOLDERS RECEIVE NOTICE WHEN CALLIDUS PROPOSES TO ENTER INTO A SETTLEMENT OF THIS
KIND OF CASE. YOU ARE NOT REQUIRED TO TAKE ANY ACTION. THERE IS NO CLAIM PROCEDURE AND YOU
WILL NOT RECEIVE ANY FUNDS PURSUANT TO THIS SETTLEMENT. IT IS NOT NECESSARY FOR ANY CALLIDUS
SHAREHOLDER TO APPEAR AT THE HEARING.

PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. THE RIGHTS OF CALLIDUS AND OF ANY
SHAREHOLDER SEEKING TO ACT DERIVATIVELY ON ITS BEHALF WILL BE AFFECTED BY THE SETTLEMENT
DESCRIBED BELOW.

IF YOU ARE RECEIVING THIS NOTICE AS NOMINEE OR OTHER REPRESENTATIVE OF A BENEFICIAL OWNER OF
CALLIDUS COMMON STOCK, PLEASE FORWARD THIS NOTICE TO THE BENEFICIAL OWNER (ADDITIONAL COPIES MAY
BE OBTAINED FROM THE ADDRESS GIVEN BELOW).

THE COURT HAS NOT DECIDED THE MERIT OF ANY CLAIM OR DEFENSE ASSERTED BY THE PARTIES IN THIS
CASE. NO INFERENCE REGARDING THE MERITS OF THE CASE SHOULD BE DRAWN FROM SETTLEMENT OF THE CASE
OR THE SENDING OF THIS NOTICE.

THE DERIVATIVE ACTIONS

     This case was filed in October 2004 by Callidus shareholder Henry Ramseur, derivatively on
behalf of Callidus, against certain of Callidus’ present and former officers and directors. A
substantially similar case was filed by another shareholder on behalf of Callidus in California
state court in Santa Clara County in July 2004. Plaintiffs’ counsel in the two cases have
coordinated their activities, and both cases are being settled in the settlement described below.

     The first amended complaint in this case alleges that defendants violated their fiduciary
duties to Callidus by authorizing the public financial guidance released by the company regarding
its expected financial results for the first and second quarters of 2004. Plaintiff claims that
the defendants did not have a reasonable basis for the guidance and that, when the company’s
financial results for those two quarters fell short of the guidance, the company was damaged by,
among other things, being subjected to a class-action lawsuit on behalf of shareholders who had
purchased Callidus stock between the time the guidance was given and the time the actual results
were disclosed.

     The class-action lawsuit was dismissed by the Court in May 2005, with leave to file an amended
complaint. After lead counsel for the class did not file an amended complaint, the Court dismissed
the class action with prejudice in July 2005.

     Following dismissal of the class action, Callidus provided to the plaintiffs in both
derivative cases the documents that were available to the Callidus board when it authorized the
guidance Callidus gave for the first two quarters of 2004. Plaintiff amended his complaint to
include information provided in these documents. The defendants then filed a motion to dismiss
this case, asserting that plaintiff had failed to plead particularized facts raising a reasonable
doubt as to the Board’s ability to disinterestedly and independently evaluate a demand to bring
this action, such that a demand would have been futile. Defendants also contended in their motion
that plaintiff had not stated facts in his complaint sufficient to constitute a claim for relief.

EXHIBIT C

 

 

     The Court denied defendants’ motion to dismiss in March 2006. A settlement conference held on
August 1, 2006 before United States Magistrate Judge Hon. Joseph C. Spero was attended by counsel
for plaintiffs in both actions, counsel for the defendants, a number of the defendants themselves,
and representatives of Callidus and its Directors and Officers Liability Insurance carrier, Genesis
Insurance Company (“Genesis”). Discussions prior to and at the settlement conference and over
several days thereafter have resulted in the settlement described below (the “Settlement”).

THE SETTLEMENT

     A Stipulation of Settlement (the “Stipulation”) was filed with the Court on August 11, 2006.
A full copy of the Stipulation may be obtained from the Clerk’s Office during normal business
hours. In summary, the principal terms of the Settlement are as follows:

	 	•	 	Callidus will adopt or reconfirm a series of corporate governance policies that counsel
for the plaintiffs believe will advance shareholder democracy at Callidus and strengthen
the company’s controls in a number of respects, and will keep them in effect for at least
three years. These include:

	 	•	 	adoption of a “Pfizer style” policy for election of directors requiring any
nominee who receives more “withhold” than “for” votes in an uncontested election to
tender a resignation, which the Nominating and Governance Committee, or full board, can
accept or reject;
	 
	 	•	 	continuing to elect its Chairman from among its independent directors;
	 
	 	•	 	amending its Corporate Governance Guidelines to require that management keep the
board informed of all information relevant to the board’s performance of its duties;
	 
	 	•	 	putting performance reviews of executive officers in writing and requiring board
approval of any performance-based compensation outside of established written plans;
	 
	 	•	 	formalizing its policies that prevent the backdating of stock option grants and
requiring regular review of option exercises;
	 
	 	•	 	including consideration of imposing a trading freeze as a formal agenda item for
all regularly scheduled board meetings;
	 
	 	•	 	amending the general counsel’s job description to include formal oversight and
administration of the company’s Code of Conduct and to require direct reporting to the
Audit Committee regarding the Code of Conduct and compliance issues;
	 
	 	•	 	requiring the Audit Committee to review all revenue and earnings guidance
proposed to be given by the company, including participation by the CEO, CFO and any
other executive or employee the Committee deems appropriate;
	 
	 	•	 	requiring management to provide to the Audit Committee all information the
Committee deems necessary to support any proposed guidance, and to provide a detailed
history of the company’s prior guidance and actual results, including the reasons for
any discrepancy between prior guidance and actual results.

	 	•	 	Genesis will pay $397,000 to plaintiffs’ counsel as attorney’s fees and expenses and
$1,500 to each of the named plaintiffs as an incentive award, resulting in total payments
by Genesis of $400,000.
	 
	 	•	 	Both derivative actions will be dismissed with prejudice, and all claims against the
defendants in either case, or other Callidus directors or officers, that were raised or
could have been raised in either of the actions by Callidus or by any shareholder
derivatively on its behalf will be released, including without limitation any matter
insured under the Genesis insurance policy and any claims that are currently unknown or
unsuspected (other than claims relating to any backdating of Callidus stock option grants
that may hereafter be discovered).

     The above description is only a summary of the key terms of the Settlement and does not
include all of the details contained in the Stipulation.

     The case is being settled because, while all parties are confident of prevailing if the
litigation were to proceed, they also recognize the risks that their evaluations might not prove
accurate and that continuing the litigation could be expensive for all parties. Callidus also
views the corporate governance policies that will be adopted, formalized or reconfirmed as part of
the Settlement as beneficial to Callidus and its shareholders.

     The Settlement is subject to final approval by the Court and will not become effective until a
judgment approving the Settlement has become final and no longer subject to appeal.

THE SETTLEMENT APPROVAL HEARING

     Any current Callidus shareholder may appear at the October 27, 2006 final approval hearing and
show cause, if any, why the Settlement should or should not be approved; provided, however, that no
shareholder will be heard unless, at least 10 days prior to the hearing, he or she has filed with
the Court a written statement of his or her position, together with any supporting papers
demonstrating ownership of Callidus stock and showing proof of service of the papers on the
following counsel: (1) Co-Lead Derivative Counsel: Justice Reed, Schubert & Reed LLP, Three
Embarcadero Center, Suite 1650, San Francisco, CA 94111, (415) 788-4220 and (2) Counsel for
Defendants: William F. Alderman, Orrick Herrington & Sutcliffe LLP, The Orrick Building, 405
Howard Street, San Francisco, CA 94105.

     Unless otherwise directed by the Court, any Callidus shareholder who has not made an objection
to the Settlement in the manner described above will be deemed to have waived it.

INQUIRIES

     Should you have any questions concerning the derivative actions or this Notice, you should
raise them with your own counsel or direct them to co-lead derivative counsel: Juden Justice Reed,
Schubert & Reed LLP, Three Embarcadero Center, Suite 1650, San Francisco, CA 94111

     If you are a nominee or other representative of a beneficial owner of Callidus stock and need
additional copies of this Notice to forward to the beneficial owner(s), please request them from:
Geraldine Zarbo, American Stock Transfer and Trust Company, 6201 15th Avenue, Brooklyn, NY 11219.

	 	 	 
	Dated: August 21, 2006

	 	By Order of the United States District Court for the Northern District of California

- 2 -

 

ROBERT C. SCHUBERT (STATE BAR NO. 62684)

JUDEN JUSTICE REED (STATE BAR NO. 153748)

WILLEM F. JONCKHEER (STATE BAR NO. 178748)

AARON H. DARSKY (STATE BAR NO. 212229)

SCHUBERT & REED LLP

Three Embarcadero Center, Suite 1650

San Francisco, CA 94111

Telephone: (415) 788-4220

BRIAN J. ROBBINS (STATE BAR NO. 190264)

MARC M. UMEDA (STATE BAR NO. 197847)

ROBBINS UMEDA & FINK, LLP

610 West Ash Street, Suite 1800

San Diego, CA 92101

Telephone: (619) 525-3990

Facsimile: (619) 525-3991

Attorneys for Plaintiff Henry Ramseur, Derivatively

on behalf of Callidus Software Inc.

WILLIAM F. ALDERMAN (STATE BAR NO. 47381)

JAMES N. KRAMER (STATE BAR NO. 154709)

M. TODD SCOTT (STATE BAR NO. 226885)

ORRICK, HERRINGTON & SUTCLIFFE LLP

The Orrick Building

405 Howard Street

San Francisco, CA 94105-2669

Telephone: 415-773-5700

Facsimile: 415-773-5759

Attorneys for Defendants

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

	 	 	 	 	 	 
	HENRY RAMSEUR, Derivatively on behalf	 	 	(PROPOSED) ORDER AND FINAL
	of CALLIDUS SOFTWARE INC., a	 	 	JUDGMENT APPROVING
	DELAWARE CORPORATION,	 	 	SETTLEMENT
	 
	 	 	 	 	 
	                    Plaintiff,	 	 	 
	 
	 	 	 	 	 
	          v.	 	 	 
	 
	 	 	 	 	 
	GEORGE JAMES, R. DAVID SPRENG,	 	 	 
	TERRY L. OPDENDYK, MICHAEL A.	 	 	 
	BRAUN, JOHN R. EICKHOFF,	 	 	 
	CHRISTOPHER W. CABRERA and REED	 	 	 
	D. TAUSSIG,	 	 	 
	 
	 	 	 	 	 
	                    Defendants.	 	 	 
	 
	 	 	 	 	 
	          — and —	 	 	 
	 
	 	 	 	 	 
	CALLIDUS SOFTWARE INC., a	 	 	 
	DELAWARE CORPORATION,	 	 	 
	 
	 	 	 	 	 
	 
	 	 	 	 	 
	                    Nominal Defendant.	 	 	 
	 
	 	 	 	 	 
	 	 	 	 

EXHIBIT D

(PROPOSED) ORDER AND FINAL JUDGMENT

APPROVING SETTLEMENT

 

 

          This matter came before the Court on October 27, 2006, pursuant to the Court’s Preliminary
Approval Order dated August 11, 2006, on the application of the parties for final approval of the
proposed settlement (the “Settlement”) of this derivative action described in the Stipulation of
Settlement, dated as of August 11, 2006 and filed with the Court on August 11, 2006 (the
“Stipulation”).

          Due and adequate Notice having been given to the shareholders of Callidus Software Inc.
(“Callidus”) as required by the Preliminary Approval Order, the Court having considered all papers
filed in connection with the proposed Settlement and having concluded that the Settlement is fair,
reasonable and adequate and in the best interests of Callidus, and good cause appearing therefor,
it is hereby

          ORDERED, ADJUDGED and DECREED as follows:

          1. This Court has jurisdiction over the subject matter of this action and over all of the
parties to this action.

          2. Pursuant to Rule 23.1 of the Federal Rules of Civil Procedure (“Rule 23.1”), the Court
approves the Settlement described in the Stipulation, finds that in all respects the Settlement is
fair, reasonable and adequate and in the best interests of Callidus, and directs the parties to
perform the terms set forth in the Stipulation.

          3. This action, all claims contained therein, and all claims released in paragraph 3 of the
Stipulation are dismissed with prejudice. Except as otherwise provided in the Stipulation, the
parties shall bear their own costs, expenses and attorney’s fees.

          4. Upon the Effective Date of the Settlement, as described in paragraph 8 of

EXHIBIT D

(PROPOSED) ORDER AND FINAL JUDGMENT

APPROVING SETTLEMENT

- 2 -

 

the Stipulation, Callidus, and each of its present or former shareholders to the extent they
seek to sue derivatively on its behalf, shall be deemed to release and forever discharge each of
the defendants and other parties described in paragraph 3 of the Stipulation from and against all
Claims described in said paragraph 3. All Callidus shareholders are hereby forever barred and
enjoined from prosecuting any Claims released in said paragraph 3.

          5. The mailing and posting of the Notice in the manner described in the Preliminary Approval
Order constitutes due and adequate notice under Rule 23.1 and satisfies the requirements of due
process.

          6. The Court finds that the attorney’s fees, expenses and incentive awards described
in paragraph of the Stipulation are fair and reasonable in light of the time and expense incurred
by plaintiffs and their counsel and the benefits to Callidus provided by the Settlement, and hereby
specifically approves them.

          7. Jurisdiction over all matters relating to consummation of the Settlement is hereby reserved
in this Court.

     Dated:                                         

	 	 	 
	 

	 	 

United States District Judge

EXHIBIT D

(PROPOSED) ORDER AND FINAL JUDGMENT

APPROVING SETTLEMENT

- 3 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]